Back to Trades
Bausch Christoph Lawrence
InsiderCIK 0001889981
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Bausch Christoph Lawrence has filed 2 SEC reports (2025–2026), all concentrated in SAB Biotherapeutics, Inc. (SABS), totaling $9.3M in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Feb 5 | SABS SAB Biotherapeutics, Inc. | Bausch Christoph Lawrence | Insider | Award | $8.0M |
| Aug 28 | SABS SAB Biotherapeutics, Inc. | Bausch Christoph Lawrence | Insider | Award | $1.3M |
2 filings